2 results
Approved WMOCompleted
To evaluate the safety and clinical performance of the LCP system in patients who are indicated for VVI(R) pacemaker.
Approved WMOCompleted
Primary Objective:* To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on exercise capacity as determined by cardiopulmonary exercise testing (CPET) following 20 weeks of treatment with OM or placeboSecondary…